|Day Low/High||3.36 / 3.55|
|52 Wk Low/High||1.80 / 9.65|
Substantially reduced debt and improved balance sheet strengthens Alphatec's financial position and enables future growth strategies
Shares of Common Stock Will Begin Trading on a Split-Adjusted Basis on August 25, 2016
Cash proceeds of $80 million to substantially reduce Company's outstanding debt, allow for continued investment in commercialization and expansion of U.S. business
The $1 billion transaction could inspire other medical device companies and private equity firms to bend over backwards for spinal device assets.
Company Announces Extension of Credit Agreement Maturity
These five stocks look ready to trigger big breakout trades.
Stocks with insider trader activity include CBG, RPTP and ATEC
Company Posts Record Sales and Adjusted EBITDA for Both Fourth Quarter and Full Year 2014